Page: Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence - Scientific guideline-2025/6/17

Document: Outcome of public consultation on the reflection paper use of real-world data in non-interventional studies to generate real-world evidence for regulatory purposes - Summary report of comments received during the public consultation and next ste

Document: Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence for regulatory purposes-2025/6/17

Document: Abbreviations used in EMA scientific committees and Coordination Group for Mutual Recognition and Decentralised Procedures (CMD) documents, and in relation to EMA’s regulatory activities-2025/6/17

Page: Anti-fraud strategy-2025/6/17

Document: European Medicines Agency's anti-fraud strategy - revised June 2025-2025/6/17

Document: Agenda - PDCO agenda of the 17-20 June 2025 meeting-2025/6/17

Document: Orientation guide for industry - EMA building-2025/6/16

Document: Orientation guide for patient representatives and healthcare professionals - EMA building-2025/6/16

Document: Orientation guide for delegates - EMA building-2025/6/16